Miraculous Medicines

teleport me to a random drug
Minted: - / 5000

1291 Ribociclib
9758ae68d55c339c4f38cb194c88a2154471aa69ecaeca3c0add7888ca68fcd1

This DRUG has not been minted yet.
Mint it now with MetaMask!

Send:
ETH
and donate to medical research.
Note: transaction fees shown in metamask are an approximation and are likely to be smaller.

Properties

Chemistry

Ribociclib, sold under the brand name Kisqali & Kryxana both marketed by Novartis, is an inhibitor of cyclin D1/CDK4 and CDK6, and is used for the treatment of certain kinds of breast cancer. Ribociclib is a kinase inhibitor indicated in combination with: an aromatase inhibitor for the treatment of pre/perimenopausal or postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer, as initial endocrine-based therapy; or fulvestrant for the treatment of postmenopausal women with HR-positive, HER2-negative advanced or metastatic breast cancer, as initial endocrine-based therapy or following disease progression on endocrine therapy. It is also being studied as a treatment for other drug-resistant cancers. It was developed by Novartis and Astex Pharmaceuticals.

From Wikipedia, the free encyclopedia. License: CC BY-SA.
≪ Previous
1290 Next ≫
1292
Made with on Earth by F. Boffa and T. Calemme
This website does not track you.
Read the contract on Etherscan